Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Assets: 2016-2025

Historic Assets for Anaptysbio (ANAB) over the last 9 years, with Sep 2025 value amounting to $353.1 million.

  • Anaptysbio's Assets fell 28.44% to $353.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $353.1 million, marking a year-over-year decrease of 28.44%. This contributed to the annual value of $483.8 million for FY2024, which is 6.95% up from last year.
  • Latest data reveals that Anaptysbio reported Assets of $353.1 million as of Q3 2025, which was up 5.32% from $335.2 million recorded in Q2 2025.
  • Anaptysbio's 5-year Assets high stood at $643.1 million for Q4 2021, and its period low was $335.2 million during Q2 2025.
  • Its 3-year average for Assets is $448.1 million, with a median of $452.4 million in 2023.
  • In the last 5 years, Anaptysbio's Assets spiked by 57.70% in 2022 and then fell by 28.44% in 2025.
  • Over the past 5 years, Anaptysbio's Assets (Quarterly) stood at $643.1 million in 2021, then dropped by 5.08% to $610.4 million in 2022, then fell by 25.88% to $452.4 million in 2023, then rose by 6.95% to $483.8 million in 2024, then fell by 28.44% to $353.1 million in 2025.
  • Its Assets stands at $353.1 million for Q3 2025, versus $335.2 million for Q2 2025 and $422.1 million for Q1 2025.